Journal
DIABETES TECHNOLOGY & THERAPEUTICS
Volume 20, Issue 7, Pages 501-505Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/dia.2018.0060
Keywords
Diabetes; Pregnancy; Closed loop; Insulin; Labor and delivery
Categories
Funding
- National Institute for Health Research (HRM Career Development Fellowship) [CDF-2013-06-035]
- Diabetes UK [BDA 07/0003551]
- Gates Cambridge Trust PhD fellowship
- Jean Hailes for Women's Health
- Allen-Carey Scholarship in Women's Health
- NIHR Cambridge Biomedical Research Center
- National Institute for Health Research
Ask authors/readers for more resources
Tight glucose control during labor and delivery is recommended for pregnant women with type 1 diabetes. This can be challenging to achieve using the current treatment modalities. The automated nature of closed loop and its ability to adapt to real-time glucose levels make it well suited for use during labor, delivery, and the immediate postpartum period. We report observational data of participants from two randomized crossover trials who chose to continue using closed loop during labor, delivery, and postpartum. Labor was defined as the 24h before delivery and postpartum as the 48h after delivery. The glucose target range during pregnancy was 3.5-7.8mmol/L (63-140mg/dL) and 3.9-10mmol/L (70-180mg/dL) after delivery. Twenty-seven (84.4%) of the potential 32 trial participants used closed loop through labor, delivery, and postpartum. Use of closed loop was associated with 82.0% (interquartile range [IQR] 49.3, 93.0) time-in-target range during labor and delivery and a mean glucose of 6.9 +/- 1.4mmol/L (124 +/- 25mg/dL). Closed loop performed well throughout vaginal, elective, and emergency cesarean section deliveries. Postpartum, women spent 83.3% (IQR 75.2, 94.6) time-in-target range (3.9-10.0mmol/L [70-180mg/dL]), with a mean glucose of 7.2 +/- 1.4mmol/L (130 +/- 25mg/dL). There was no difference in maternal glucose concentration between mothers of infants with and without neonatal hypoglycemia (6.9 +/- 1.6mmol/L and 6.8 +/- 1.1mmol/L [124 +/- 29mg/dL and 122 +/- 20mg/dL] respectively; P=0.84). Automated closed-loop insulin delivery is feasible during hospital admissions for labor, delivery, and postpartum. Larger scale studies are needed to evaluate its efficacy compared with current clinical approaches as well as understand how women and healthcare providers will adopt this technology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available